Significant Revenue Growth in Treatment Segment
Revenue in the Treatment segment increased by approximately 37% compared to the same period last year, with waste receipts more than doubling to approximately $14 million in Q2 of 2025.
Improvement in Gross Margin
The company reported a meaningful improvement in gross margin, with gross profit for the quarter at $1.5 million compared to a negative $1.3 million in Q2 of 2024.
RADMAC III IDIQ Contract Award
The company was awarded a position on the Navy's $240 million RADMAC III IDIQ contract, strengthening its core competencies in radiological cleanup.
International Expansion and Contracts
Received over $7 million in waste receipts from international customers in the past two quarters, and the EUR 50 million contract with the EU in Italy is progressing as planned.
Strong Waste Backlog
Company-wide waste backlog stands at approximately $13.2 million, providing strong visibility into the second half treatment volumes and services activities.